Search Results

Medicine has gone to two researchers whose pioneering work relied on mice to develop messenger RNA (mRNA) vaccines for Covid-19. This meant that mRNA vaccines for Covid-19 could be developed at an unprecedented rate, during ‘one of Read more about mRNA vaccines.

A therapy, based on the same messenger RNA (mRNA) technology used in Covid-19 vaccines, has successfully Great Ormond Street Institute of Child Health, said: “Messenger RNA has revolutionised the field of vaccines during the COVID-19 pandemic.

A trial vaccine for Covid-19, which is delivered up the nose, provides better protection than an injection Berlin, Charité – Universitätsmedizin Berlin, and the Max Delbrück Center, all EARA members, targets the vaccine Hamsters are important for studying Covid-19, because they are naturally infected by the same variants The researchers used the nasal vaccine on hamsters with Covid-19 and found that it stopped the virus The researchers also compared the effect of hamsters given the nasal vaccine compared to a vaccine injected

Scientists from the Yale School of Medicine, USA, have found that nasal vaccines could potentially provide In the study, published in Science Immunology, the team tested vaccines against influenza viruses administrated exposing mice to multiple strains of influenza viruses, they observed that mice which received the nasal vaccine The Yale team is now testing nasal vaccines against Covid strains in animal models.

A leading member of the Oxford Vaccine Group, developers of the Oxford-AstraZeneca Covid-19 vaccine, animal studies and said: “If the animal trials showed the vaccine was not safe, or not effective, we misinformation, including by members of the European Parliament, stating that animals were not needed in Covid -19 vaccine research. Dame Sarah also warned about the need for better funding for vaccine development.

Recent studies have shown that vaccine technology used for Covid-19 has been effective in halting the In collaboration with EARA member, Sanofi, the Covid vaccine developer, BioNTech, Germany, has created

US studies, using animals, have uncovered new information about the long-term effects of Covid-19 and Some people who contract Covid-19 develop long-lasting symptoms that persist even after they have recovered – a potentially serious group of conditions known as long Covid . The team studied monkeys with Covid-19 and found that after a Covid-19 mRNA vaccination  the animals , which can happen when the Covid-19 virus leaves behind proteins in the blood after an infection.

BioNTech, the German company involved in production of the first approved Covid-19 vaccine, is now applying its vaccine technology in multiple sclerosis research (MS). This is the first application of mRNA vaccine technology for the treatment of an autoimmune disease, In collaboration with Johannes Gutenberg University of Mainz, the team has produced a vaccine which aims The vaccine appears to improve symptoms of MS in mice with severe symptoms, while preventing progression

researchers have gained insights into how bats resist getting ill from the SARS-CoV-2 virus, which causes Covid First author Punam Bisht said: “Filling in these gaps in our knowledge will help us develop better vaccines

Researchers in the US have developed a type of microparticle, that can deliver and release vaccines at set times, to create a single dose ‘self-boosting” vaccine’. Vaccination programmes for diseases such as Covid-19 or polio, require multiple shots to protect the recipient, but poor patient attendance on vaccination programmes is a significant problem, particularly , have developed microparticles which resemble tiny coffee cups sealed with a lid, that contain the vaccine

facility in Louisiana, USA, has highlighted the importance of studies using monkeys in the fight against Covid have already provided answers about the nature of the virus and the facilities plans to study ‘long-Covid not only the disease and how it affects the organism, but also to compare treatments, therapies and vaccinations

This condition is similar to the immune dysregulation seen in some people with long COVID.  Because FIP shares several features with COVID-19, the study published in Stem Cells Translational Medicine